Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Cancers|December 8, 2019
The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated DegradationOlivier Mansier, Valérie Prouzet-Mauléon, Gwénaële Jégou, et al.
Cancer Medicine|February 24, 2024
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapyHarmony Leroy, Noémie Gadaud, Emilie Bérard, et al.
Blood Advances|May 19, 2023
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA studyLoïc Vasseur, Laurène Fenwarth, Jérôme Lambert, et al.
Cancers|July 30, 2020
Real-World Outcomes of Patients with Refractory or Relapsed <i>FLT3</i>-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry StudyPierre-Yves Dumas, Sarah Bertoli, Emilie Bérard, et al.
Cancers|March 29, 2020
Outcome of Relapsed or Refractory <i>FLT3</i>-Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse-Bordeaux DATAML Registry StudySarah Bertoli, Pierre-Yves Dumas, Emilie Bérard, et al.
Blood Advances|August 14, 2020
Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcomePierre-Yves Dumas, Sarah Bertoli, Emilie Bérard, et al.
Haematologica|March 30, 2019
Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib <i>via</i> STAT5-and hypoxia-dependent upregulation of AXLPierre-Yves Dumas, Cécile Naudin, Séverine Martin-Lannerée, et al.
European Journal of Haematology|March 18, 2021
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional statusClaire Jouzier, Jean-François Hamel, Pierre-Yves Dumas, et al.
Leukemia|July 17, 2024
Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia - a FILO studyCorentin Orvain, Sarah Bertoli, Pierre Peterlin, et al.
Open Forum Infectious Diseases|March 12, 2025
Levofloxacin to Prevent Bacterial Infection in Patients With Acute Myeloid Leukemia Treated by Venetoclax and Azacitidine: A Toulouse-Bordeaux DATAML Registry StudyXavier Brousse, Nicolas Rasandisona, Emilie Bérard, et al.
Pageof 7